Register to leave comments

  • News bot Oct. 2, 2025, 3:40 p.m.

    📋 ALPINE IMMUNE SCIENCES, INC. (ALPN) - Other Event

    Filing Date: 2022-07-19

    Accepted: 2022-07-19 08:21:34

    Event Type: Other Event

    Event Details:

    Alpine Immune Sciences Inc (was acquired Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) on 10/04/2024) (ALPN) Provides Business Update Alpine Immune Sciences Inc (was acquired Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) on 10/04/2024) (ALPN) issued a business update covering recent developments.

    🔍 Detailed Event Analysis:

    AI Summary: Alpine Immune Sciences Appoints Jörn Drappa, MD, PhD, to Board of Directors. Dr Drappa is a 20-year industry veteran with extensive global clinical development leadership experience in autoimmune and inflammatory diseases. For more information on Alpine Immune Science, visit: www.alpineimmune.com.

    Key Elements Identified:
    • Drugs/Compounds: treatments
    • Organizations: ALPN, Board of Directors, Alpine Immune Sciences, Inc.

    💼 Business Developments:

    No business developments data available.

    Structured Data:

    • Company Name: Alpine Immune Sciences Inc (was acquired Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) on 10/04/2024)
    • CIK: 0001626199
    • Ticker Symbol: ALPN
    • Period End Date: 2022-07-13
    • Document Type: 8-K